Ramin Esmail Beygui, MD
Thoracic Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 36 years
- University of California, Irvine, California College of Medicine, 1990
Offices
2 locations · UCSF Dept of Surgery · UCSF Medical Group Business Services
Hospitals listed: UCSF Medical Center · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Beygui’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G73011 · Current
Licensed to practise in California · since 1991 · expires 2027-07-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$102,061
Medicare paid this office $102,061 for 82 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Coronary artery bypass using artery graft, 1 graft | 15 | $22,477 | $1,498 |
| Replacement of aortic valve through the skin and femoral artery | 12 | $7,397 | $616 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 14 | $4,614 | $330 |
| New patient visit (45+ min) | 15 | $1,788 | $119 |
| Harvest of vein using an endoscope | 17 | $221 | $13 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 19 | More than 65% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Coronary artery bypass using artery graft, 1 graft | 19 | 30 | 24 | 25 | 12 | 15 |
| Harvest of vein using an endoscope | 17 | 31 | 24 | 22 | 13 | 17 |
| Replacement of aortic valve through the skin and femoral artery | 24 | 16 | 19 | 14 | – | 12 |
| Coronary artery bypass using vein or artery graft, 2 grafts | – | 17 | 11 | 11 | – | 14 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
82 Original Medicare patients in 2024. Average age 71 · Women 37% · Also on Medicaid 37% · Health risk score 2.44. Above the middle of the specialty; the typical thoracic surgery clinician is at 1.74.
Conditions among them: High blood pressure 75% · Coronary heart disease 72% · Heart failure 55% · Atrial fibrillation 54% · Chronic kidney disease 51% · Diabetes 41% · COPD 29% · Depression 26% · Cancer 17% · Stroke 17% · Dementia 13%.
The office billed $906,926, Medicare allowed $127,870 and paid $102,061; for 183 services of 55 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 82 | 183 | 71 | 2.44 | $906,926 | $102,061 |
| 2023 | 69 | 137 | 74 | 1.94 | $588,255 | $78,334 |
| 2022 | 83 | 174 | 75 | 1.97 | $665,872 | $89,433 |
| 2021 | 84 | 190 | 74 | 2.07 | $772,780 | $111,698 |
| 2020 | 81 | 207 | 73 | 2.13 | $833,172 | $124,316 |
| 2019 | 139 | 253 | 76 | 2.32 | $847,661 | $124,755 |
| 2018 | 129 | 283 | 73 | 2.26 | $964,231 | $141,419 |
| 2017 | 112 | 228 | 74 | 2.52 | $725,506 | $105,830 |
| 2016 | 129 | 214 | 73 | 2.83 | $429,697 | $72,737 |
| 2015 | 203 | 472 | 71 | 2.53 | $472,421 | $139,650 |
| 2014 | 91 | 167 | 71 | 2.32 | $441,172 | $72,938 |
| 2013 | 73 | 165 | 69 | 1.98 | $777,330 | $108,088 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Coronary artery bypass using artery graft, 1 graft | 12 | $18,731 | $1,561 |
| New patient visit (45+ min) | 11 | $1,308 | $119 |
| Harvest of vein using an endoscope | 13 | $171 | $13 |
2022: 5 services
| Coronary artery bypass using artery graft, 1 graft | 25 | $38,005 | $1,520 |
| Replacement of aortic valve through the skin and femoral artery | 14 | $8,923 | $637 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 11 | $3,747 | $341 |
| New patient visit (45+ min) | 17 | $1,976 | $116 |
| Harvest of vein using an endoscope | 22 | $297 | $13 |
2021: 5 services
| Coronary artery bypass using artery graft, 1 graft | 24 | $34,369 | $1,432 |
| Replacement of aortic valve through the skin and femoral artery | 19 | $12,204 | $642 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 11 | $3,851 | $350 |
| New patient visit (45+ min) | 11 | $1,393 | $127 |
| Harvest of vein using an endoscope | 24 | $315 | $13 |
2020: 5 services
| Coronary artery bypass using artery graft, 1 graft | 30 | $48,390 | $1,613 |
| Replacement of aortic valve through the skin and femoral artery | 16 | $10,656 | $666 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 17 | $6,088 | $358 |
| New patient visit (45+ min) | 11 | $1,251 | $114 |
| Harvest of vein using an endoscope | 31 | $439 | $14 |
2019: 6 services
| Coronary artery bypass using artery graft, 1 graft | 19 | $28,235 | $1,486 |
| Replacement of aortic valve through the skin and femoral artery | 24 | $17,503 | $729 |
| Long return visit (40+ min) | 28 | $3,590 | $100 |
| New patient visit (30+ min) | 31 | $2,034 | $66 |
| New patient visit (45+ min) | 15 | $1,729 | $115 |
| Harvest of vein using an endoscope | 17 | $235 | $14 |
2018: 9 services
| Coronary artery bypass using artery graft, 1 graft | 30 | $44,559 | $1,485 |
| Replacement of aortic valve on heart-lung machine | 12 | $17,861 | $1,488 |
| Replacement of aortic valve through the skin and femoral artery | 19 | $13,667 | $719 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 19 | $6,551 | $345 |
| New patient visit (60+ min) | 11 | $1,569 | $143 |
| New patient visit (45+ min) | 13 | $1,369 | $105 |
| Long return visit (40+ min) | 13 | $1,185 | $91 |
| New patient visit (30+ min) | 15 | $972 | $65 |
| Harvest of vein using an endoscope | 30 | $408 | $14 |
2017: 4 services
| Coronary artery bypass using artery graft, 1 graft | 19 | $25,227 | $1,328 |
| Replacement of aortic valve through the skin and femoral artery | 11 | $7,408 | $673 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 11 | $3,254 | $296 |
| Harvest of vein using an endoscope | 19 | $236 | $12 |
2016: 5 services
| Coronary artery bypass using artery graft, 1 graft | 15 | $14,061 | $937 |
| New patient visit (45+ min) | 15 | $1,405 | $94 |
| Return visit (30+ min) | 18 | $1,200 | $63 |
| Short return visit (20+ min) | 14 | $358 | $26 |
| Short return visit | 12 | $239 | $18 |
2015: 11 services
| Coronary artery bypass using artery graft, 1 graft | 21 | $32,375 | $1,542 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 23 | $13,149 | $572 |
| New patient visit (45+ min) | 45 | $6,506 | $145 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 15 | $5,148 | $343 |
| New patient visit (30+ min) | 46 | $4,463 | $97 |
| Short return visit | 64 | $3,475 | $39 |
| New patient visit (60+ min) | 14 | $2,538 | $181 |
| Short return visit (20+ min) | 28 | $1,985 | $64 |
| Long return visit (40+ min) | 11 | $1,353 | $123 |
| New patient visit (15+ min) | 18 | $1,232 | $68 |
| Harvest of vein using an endoscope | 22 | $293 | $13 |
2014: 2 services
| New patient visit (45+ min) | 16 | $2,332 | $146 |
| New patient visit (30+ min) | 12 | $1,153 | $96 |
Drugs they prescribed that Part D paid
$5,113
Pharmacies billed $5,113 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 62) in 2024. At or below the middle of the specialty; the typical thoracic surgery clinician is at 2%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
57 generic and fewer than 11 brand-name prescriptions · $5,113 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clopidogrel | 11 | $128 | $12 |
Year by year
| 2024 | 62 | 15 | 0% (0) | None | $5,113 |
| 2023 | 73 | 17 | 0% (0) | 30% | $14,621 |
| 2022 | 93 | 25 | None | None | $4,363 |
| 2021 | 143 | 31 | None | 15% | $4,816 |
| 2020 | 163 | 35 | None | None | $9,627 |
| 2019 | 215 | 43 | None | None | $10,049 |
| 2018 | 153 | 40 | 12% (19) | 8% | $2,570 |
| 2017 | 130 | 26 | None | 17% | $15,958 |
| 2016 | 165 | 39 | 10% (17) | 7% | $3,325 |
| 2015 | 266 | 43 | 13% (35) | 5% | $4,395 |
| 2014 | 40 | 19 | None | None | $1,954 |
| 2013 | 38 | 19 | None | None | $1,955 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Clopidogrel | 12 | $255 | $21 |
2022: 1 drug
| Metoprolol | 17 | $103 | $6 |
2021: 2 drugs
| Clopidogrel | 17 | $305 | $18 |
| Atorvastatin | 16 | $109 | $7 |
2020: 4 drugs
| Metoprolol | 17 | $263 | $15 |
| Clopidogrel | 20 | $237 | $12 |
| Atorvastatin | 17 | $193 | $11 |
| Metoprolol | 17 | $90 | $5 |
2019: 6 drugs
| Clopidogrel | 33 | $395 | $12 |
| Atorvastatin | 18 | $276 | $15 |
| Potassium Chloride | 11 | $209 | $19 |
| Metoprolol | 34 | $164 | $5 |
| Amiodarone | 12 | $162 | $14 |
| Metformin | 11 | $52 | $5 |
2018: 5 drugs
| Metoprolol | 11 | $267 | $24 |
| Clopidogrel | 29 | $246 | $8 |
| Atorvastatin | 15 | $180 | $12 |
| Carvedilol | 16 | $84 | $5 |
| Metoprolol | 14 | $40 | $3 |
2017: 3 drugs
| Tamsulosin | 13 | $113 | $9 |
| Atorvastatin | 14 | $105 | $8 |
| Metoprolol | 13 | $77 | $6 |
2016: 6 drugs
| Metoprolol | 12 | $328 | $27 |
| Clopidogrel | 26 | $204 | $8 |
| Atorvastatin | 17 | $193 | $11 |
| Lisinopril | 14 | $95 | $7 |
| Hydrocodone-Acetaminophen | 12 | $90 | $7 |
| Metoprolol | 21 | $81 | $4 |
2015: 6 drugs
| Metoprolol | 12 | $490 | $41 |
| Clopidogrel | 46 | $407 | $9 |
| Atorvastatin | 19 | $297 | $16 |
| Hydrocodone-Acetaminophen | 32 | $244 | $8 |
| Lisinopril | 22 | $139 | $6 |
| Metoprolol | 25 | $125 | $5 |
Money from drug and device companies
$1,811 in 2025
| 2025 | 6 | 20 | None | $1,811 |
| 2024 | 4 | 21 | None | $2,563 |
| 2023 | 2 | 2 | None | $133 |
| 2022 | 3 | 5 | None | $377 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Artivion | Amds-Ascyrus Medical | $1,021 | 7 payments
|
| Edwards Lifesciences | Konect Resilia | $312 | 3 payments
|
| Abiomed | None | $268 | 2 payments
|
| AtriCure | Atriclip Laa Exclusion System | $164 | 6 payments
|
| Abbott Laboratories | Mitraclip | $28 | 1 payment
|
| Medtronic | Aquamantys(Tm) | $18 | 1 payment
|
See all 20 published payments
| AtriCure | Meals · 2025-12-18 | Atricure Cryoice Cryosphere Cryoablation System | $12 |
| Abbott Laboratories | Meals · 2025-11-07 | Mitraclip | $28 |
| Artivion | Meals · 2025-11-04 | Amds-Ascyrus Medical | $12 |
| Medtronic | Meals · 2025-10-10 | Aquamantys(Tm) | $18 |
| AtriCure | Meals · 2025-09-12 | Atriclip Laa Exclusion System | $31 |
| Artivion | Meals · 2025-08-07 | Cryovalve Sg Pulmonary Human Heart Valve | $270 |
| AtriCure | Meals · 2025-08-06 | Atriclip Laa Exclusion System | $37 |
| Abiomed | Meals · 2025-07-31 | None | $123 |
| Edwards Lifesciences | Meals · 2025-07-25 | Mitris Resilia Mitral Valve | $95 |
| Artivion | Travel · 2025-07-25 | Amds-Ascyrus Medical | $32 |
| Artivion | Meals · 2025-07-24 | Amds-Ascyrus Medical | $77 |
| Artivion | Travel · 2025-07-24 | Amds-Ascyrus Medical | $203 |
| Artivion | Travel · 2025-07-24 | Amds-Ascyrus Medical | $387 |
| AtriCure | Meals · 2025-07-21 | Synergy Ablation System | $19 |
| Edwards Lifesciences | Meals · 2025-05-15 | None | $19 |
| Edwards Lifesciences | Meals · 2025-05-04 | Konect Resilia | $198 |
| Abiomed | Meals · 2025-05-03 | None | $145 |
| AtriCure | Meals · 2025-03-13 | Atriclip Laa Exclusion System | $38 |
| Artivion | Meals · 2025-02-19 | Amds-Ascyrus Medical | $40 |
| AtriCure | Meals · 2025-01-31 | Atriclip Laa Exclusion System | $27 |
See earlier years (2024, 2023, 2022)
2024: $2,563
| W. L. Gore & Associates | Gore Tag Thoracic Endoprosthesis | $1,251 | 8 payments
|
| Artivion | Cardiac Non-Synergraft | $936 | 6 payments
|
| Cook Medical | Zenith Alpha | $227 | 2 payments
|
| Atricure | Synergy Ablation System | $150 | 5 payments
|
2023: $133
| Atricure | Atriclip Laa Exclusion System | $104 | 1 payment
|
| Edwards Lifesciences | None | $29 | 1 payment
|
2022: $377
| AtriCure | Synergy Ablation System | $306 | 3 payments
|
| Medtronic | Corevalve Evolut R | $60 | 1 payment
|
| Edwards Lifesciences | None | $12 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ATRICURE, INC. · A Multicenter Patient Registry for Outcomes From Comprehensive Ablation Treatments of Atrial Arrhythmias · 2024 | Their institution | $4,590 |
| AtriCure, Inc. · A Multicenter Patient Registry for Outcomes From Comprehensive Ablation Treatments of Atrial Arrhythmias · 2025 | Their institution | $315 |
Professional record
- NPI
- 1750315297
- Licence
- CA G73011California G73011: Current · expires 2027-07-31
- Trained
- University of California, Irvine, California College of Medicine, 1990 · 36 years ago
- Group
- UCSF Dept of Surgery · UCSF Medical Group Business Services
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Thoracic surgery (208G00000X)
- Mailing address
- 500 Parnassus Ave Ste 110, San Francisco, CA, 94143
- NPI first listed
- 2006-07-10
- NPI last updated
- 2019-04-26
This is when the NPI record was last certified, not a medical board exam.